Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$526K Sell
18,239
-100,833
-85% -$2.25M ﹤0.01% 4160
2026
Q1
$2.02M Sell
119,072
-127,779
-52% -$2.74M ﹤0.01% 2901
2025
Q4
$6.34M Sell
246,851
-718,077
-74% -$16.5M ﹤0.01% 2114
2025
Q3
$20.8M Sell
964,928
-717,922
-43% -$16.3M 0.01% 1158
2025
Q2
$37M Buy
1,682,850
+120,304
+8% +$2.64M 0.03% 706
2025
Q1
$34.9M Buy
1,562,546
+909,480
+139% +$19.6M 0.03% 638
2024
Q4
$11.3M Buy
+653,066
New +$10.1M 0.01% 1417
2023
Q4
Sell
-11,994
Closed -$408K 4535
2023
Q3
$408K Sell
11,994
-113,991
-90% -$4.3M ﹤0.01% 3502
2023
Q2
$4.96M Sell
125,985
-242,781
-66% -$8.76M 0.01% 1868
2023
Q1
$11.8M Sell
368,766
-25,043
-6% -$827K 0.01% 1228
2022
Q4
$12.3M Buy
393,809
+197,078
+100% +$7.12M 0.01% 1268
2022
Q3
$7.29M Buy
+196,731
New +$7.37M 0.01% 1674
2021
Q4
Sell
-5,051
Closed -$283K 5641
2021
Q3
$283K Buy
+5,051
New +$279K ﹤0.01% 4393
2021
Q1
Sell
-35,314
Closed -$1.5M 4390
2020
Q4
$1.5M Buy
+35,314
New +$1.15M ﹤0.01% 2747
2020
Q3
Sell
-16,668
Closed -$430K 4077
2020
Q2
$430K Buy
+16,668
New +$383K ﹤0.01% 3462
2020
Q1
Sell
-26,592
Closed -$730K 4173
2019
Q4
$730K Buy
+26,592
New +$638K ﹤0.01% 3198

Other funds holding PGNY

David Shaw's PGNY Position: Q2 2026 in Review

David Shaw reduced its Progyny (PGNY) stake by 85% in Q2 2026, selling an estimated $2.25M and leaving 18,239 shares worth $526K. The position accounts for ﹤0.01% of the portfolio, ranked #4160.

David Shaw first reported a position in PGNY in Q4 2019 and has held it in 16 quarters since. The position peaked at $37M in Q2 2025. 309 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

  • David Shaw held 18,239 shares of Progyny worth $526K as of Q2 2026.
  • David Shaw sold 100,833 Progyny shares in Q2 2026, an estimated $2.25M.
  • Progyny made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4160 holding.
  • David Shaw first reported a position in Progyny in Q4 2019 and has held it in 16 quarters since.
  • David Shaw's Progyny position peaked at $37M in Q2 2025.
  • 309 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.